QS Investors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $16.4M | Sell |
71,528
-15,787
| -18% | -$3.17M | 0.19% | 78 |
|
|
2021
Q1 | $16.3M | Sell |
87,315
-760
| -0.9% | -$149K | 0.19% | 85 |
|
|
2020
Q4 | $14.9M | Buy |
88,075
+600
| +0.7% | +$89.6K | 0.18% | 89 |
|
|
2020
Q3 | $12.9M | Sell |
87,475
-2,306
| -3% | -$357K | 0.17% | 97 |
|
|
2020
Q2 | $14.7M | Buy |
89,781
+11,137
| +14% | +$1.71M | 0.21% | 79 |
|
|
2020
Q1 | $10.9M | Sell |
78,644
-8,681
| -10% | -$1.19M | 0.17% | 109 |
|
|
2019
Q4 | $11.5M | Buy |
87,325
+288
| +0.3% | +$33.4K | 0.12% | 131 |
|
|
2019
Q3 | $9.73M | Buy |
87,037
+305
| +0.4% | +$34K | 0.11% | 147 |
|
|
2019
Q2 | $9.61M | Sell |
86,732
-54,454
| -39% | -$6.41M | 0.1% | 130 |
|
|
2019
Q1 | $18.3M | Sell |
141,186
-6,022
| -4% | -$732K | 0.2% | 67 |
|
|
2018
Q4 | $17M | Buy |
147,208
+50,642
| +52% | +$5.66M | 0.22% | 65 |
|
|
2018
Q3 | $10.4M | Sell |
96,566
-2,826
| -3% | -$283K | 0.1% | 137 |
|
|
2018
Q2 | $8.48M | Sell |
99,392
-911
| -0.9% | -$74.8K | 0.08% | 162 |
|
|
2018
Q1 | $7.76M | Buy |
100,303
+88
| +0.1% | +$7.08K | 0.08% | 160 |
|
|
2017
Q4 | $8.46M | Buy |
100,215
+1,685
| +2% | +$143K | 0.08% | 162 |
|
|
2017
Q3 | $8.43M | Sell |
98,530
-38,998
| -28% | -$3.2M | 0.07% | 177 |
|
|
2017
Q2 | $11.3M | Buy |
137,528
+23,157
| +20% | +$1.89M | 0.1% | 121 |
|
|
2017
Q1 | $9.62M | Sell |
114,371
-965
| -0.8% | -$77.3K | 0.08% | 148 |
|
|
2016
Q4 | $8.48M | Sell |
115,336
-444
| -0.4% | -$33.1K | 0.07% | 204 |
|
|
2016
Q3 | $9.29M | Sell |
115,780
-2,321
| -2% | -$186K | 0.07% | 211 |
|
|
2016
Q2 | $9.3M | Sell |
118,101
-2,559
| -2% | -$193K | 0.08% | 217 |
|
|
2016
Q1 | $8.69M | Sell |
120,660
-254,900
| -68% | -$19.3M | 0.08% | 233 |
|
|
2015
Q4 | $31.6M | Sell |
375,560
-5,164
| -1% | -$429K | 0.31% | 60 |
|
|
2015
Q3 | $31.9M | Buy |
380,724
+255,977
| +205% | +$21.6M | 0.33% | 54 |
|
|
2015
Q2 | $10.4M | Sell |
124,747
-6,456
| -5% | -$492K | 0.13% | 195 |
|
|
2015
Q1 | $9.53M | Buy |
131,203
+5,507
| +4% | +$392K | 0.11% | 218 |
|
|
2014
Q4 | $8.67M | Buy |
125,696
+90,479
| +257% | +$6.11M | 0.1% | 232 |
|
|
2014
Q3 | $2.28M | Sell |
35,217
-2,300
| -6% | -$146K | 0.06% | 225 |
|
|
2014
Q2 | $2.33M | Buy |
37,517
+3,300
| +10% | +$197K | 0.06% | 247 |
|
|
2014
Q1 | $2.01M | Sell |
34,217
-36,100
| -51% | -$2.01M | 0.06% | 256 |
|
|
2013
Q4 | $3.59M | Sell |
70,317
-308,100
| -81% | -$15.4M | 0.14% | 143 |
|
|
2013
Q3 | $19M | Sell |
378,417
-163,883
| -30% | -$8.58M | 0.82% | 26 |
|
|
2013
Q2 | $26.7M | Buy |
+542,300
| New | +$29.5M | 0.94% | 12 |
|
Other funds holding LLY
QS Investors's LLY Position: Q2 2021 in Review
QS Investors reduced its Eli Lilly (LLY) stake by 18% in Q2 2021, selling an estimated $3.17M and leaving 71,528 shares worth $16.4M. The position accounts for 0.19% of the portfolio, ranked #78.
QS Investors first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. The position peaked at $31.9M in Q3 2015. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.
- QS Investors held 71,528 shares of Eli Lilly worth $16.4M as of Q2 2021.
- QS Investors sold 15,787 Eli Lilly shares in Q2 2021, an estimated $3.17M.
- Eli Lilly made up 0.19% of QS Investors's portfolio in Q2 2021, its #78 holding.
- QS Investors first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Eli Lilly position peaked at $31.9M in Q3 2015.
- 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.